WSL
ABEO icon

Western Standard LLC’s Abeona Therapeutics ABEO Stock Holding History

Western Standard LLC’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,249,957
Closed -$6.6M – 26
2025
Q3 		$6.6M Sell
1,249,957
-841,641
-40% -$5.34M 1.96% 13
2025
Q2 		$11.9M Sell
2,091,598
-189,601
-8% -$1.08M 6.61% 4
2025
Q1 		$10.9M Buy
2,281,199
+196,781
+9% +$1.07M 6.39% 5
2024
Q4 		$11.6M Buy
2,084,418
+386,321
+23% +$2.38M 7.74% 3
2024
Q3 		$10.7M Buy
1,698,097
+110,998
+7% +$580K 10.07% 3
2024
Q2 		$6.73M Buy
1,587,099
+225,610
+17% +$1.15M 6.97% 4
2024
Q1 		$9.87M Buy
1,361,489
+553,377
+68% +$3.51M 4.73% 5
2023
Q4 		$4.05M Buy
808,112
+583,961
+261% +$2.57M 2.7% 9
2023
Q3 		$944K Hold
224,151
– – 0.85% 21
2023
Q2 		$903K Hold
224,151
– – 0.78% 22
2023
Q1 		$632K Buy
+224,151
New +$586K 0.64% 23

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Western Standard LLC's ABEO Position: Q4 2025 in Review

Western Standard LLC sold out of Abeona Therapeutics (ABEO) in Q4 2025, closing a stake of 1,249,957 shares — an estimated $6.6M sold.

Western Standard LLC first reported a position in ABEO in Q1 2023 and held it in 11 quarters. The position peaked at $11.9M in Q2 2025. 104 funds tracked by Wall St. Rank hold ABEO as of Q4 2025.

  • Western Standard LLC reported no remaining Abeona Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Western Standard LLC sold 1,249,957 Abeona Therapeutics shares in Q4 2025, an estimated $6.6M.
  • Western Standard LLC first reported a position in Abeona Therapeutics in Q1 2023 and held it in 11 quarters.
  • Western Standard LLC's Abeona Therapeutics position peaked at $11.9M in Q2 2025.
  • 104 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2025.

Based on Western Standard LLC's 13F filing for Q4 2025, filed 3 Feb 2026.